AlphaMaven AlphaMaven

ICU Venture Investment Firm Calls 2025 General Assembly, Seeks Major Capital Ceiling Increase

Reported by Theglobeandmail
Oct 28, 2026· 2 min read
Save Post LinkedIn Email
Key Takeaways
  • • ICU Girisim Sermayesi Yatirim Ortakligi A.S. (TR:ICUGS), a Turkish venture capital and publicly traded securities investment company, has called its 2025 Ordinary General Assembly for 19 November 2026 in Izmir.
  • • Shareholders will vote on lifting the registered capital ceiling from TRY 207.75 million to TRY 2 billion and extending its validity to 2030, a move that could significantly expand funding capacity for future capital increases.
  • • The agenda also covers the 2025 activity report, independent audit, financial statements, profit distribution, board discharge, remuneration, selection of the 2026 independent auditor, and a donation cap for 2026.
  • • Governance is concentrated: privileged Group A shares controlled by Mustafa Mümtaz Özkaya carry nomination rights in board elections, while the remaining float trades as Group B shares.
Summary
ICU Girisim Sermayesi Yatirim Ortakligi A.S. has called its 2025 Ordinary General Assembly for 19 November 2026 in Izmir, according to a TipRanks report carried by The Globe and Mail. The meeting will review the year's activity report, independent audit, financial statements and profit distribution proposal, and will seek approval of board discharge, remuneration and any mid-year board changes. Shareholders may attend physically or electronically, and key documents will be published on the company's website, at its headquarters and through public disclosure channels at least three weeks before the meeting.

The most consequential item on the agenda is a proposal to amend the articles of association to raise the registered capital ceiling from TRY 207.75 million to TRY 2 billion and extend its validity to 2030. The report notes that the change could significantly expand the company's funding capacity and strategic flexibility in future capital increases. The agenda also includes selecting the independent auditor for the 2026 period, informing investors about related-party transactions, collateral and donations made in 2025, and setting a donation cap for 2026.

The company operates as an investment company focused on venture capital and publicly traded securities. Its capital structure is largely composed of publicly held Group B shares, while a smaller block of privileged Group A shares controlled by Mustafa Mümtaz Özkaya holds nomination rights in board elections. TipRanks reports a current market capitalization of approximately 389.2 million TRY and an average trading volume of about 33 million shares, and displays a 'Sell' technical sentiment signal. These market data points are drawn from a third-party press release and were not independently verified by The Globe and Mail.

Go deeper than the headline

Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.

Start your free 7-day trial

Sources

1 outlet

AlphaMaven summarised this story from the reporting below. Each link opens the original article.

Theglobeandmail ICU Venture Investment Firm Calls 2025 General Assembly, Seeks Major Capital Ceiling Increase